Copyright 2009 Medical News Today Latest Endocrinology News From Medical News Today. http://www.medicalnewstoday.com/sections/endocrinology/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Fri, 20 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/171661.php http://www.medicalnewstoday.com/articles/171661.php A workshop on "Neuroeconomics and Endocrinological Economics," being held Nov. 20 and 21 at UC Davis, will be the first to bring together experts in neuroscience, economics and hormone physiology in one event, according to organizers. Neuroeconomics has emerged as a new field in recent years, as both economists and neuroscientists have used brain scanning technology such as functional magnetic resonance imaging to investigate how people make decisions. Neurology / Neuroscience Tue, 17 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/171130.php http://www.medicalnewstoday.com/articles/171130.php Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. In a national study in 1010 men, to be presented Nov. Nutrition / Diet Mon, 16 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171038.php http://www.medicalnewstoday.com/articles/171038.php Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. In a national study in 1010 men, to be presented Nov. Complementary Medicine / Alternative Medicine Sat, 14 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170961.php http://www.medicalnewstoday.com/articles/170961.php Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins. Endocrinology Sat, 14 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170964.php http://www.medicalnewstoday.com/articles/170964.php The U.S. Food and Drug Administration approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot. Heavy menstrual bleeding is reported each year by about 3 million U.S. women of reproductive age. Women with uterine fibroids may experience heavy menstrual periods. Women's Health / Gynecology Sat, 14 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170903.php http://www.medicalnewstoday.com/articles/170903.php A new study carried out at the University of Haifa has found that the hormone oxytocin, the "love hormone", which affects behaviors such as trust, empathy and generosity, also affects opposite behaviors, such as jealousy and gloating. Endocrinology Sat, 14 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170925.php http://www.medicalnewstoday.com/articles/170925.php Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) has announced that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men. Men's health Fri, 13 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170880.php http://www.medicalnewstoday.com/articles/170880.php Dwarfism, nanism, short stature, or restricted growth is a medical disorder in which the person is of abnormally short stature. According to various sources, short stature may be caused by over 200 different medical conditions. According to the LPA (Little People of America), dwarfism is defined as an adult height of 4 feet 10 inches (148 cm) or less. However, as population groups around the world have varying average statures, height definition may vary. Pediatrics / Children's Health Thu, 12 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170696.php http://www.medicalnewstoday.com/articles/170696.php Quick 'bench-to-bedside' clinical trial would enroll 1,400 influenza patients to test corticosteroids and statins as potential treatments An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic. Swine Flu Wed, 11 Nov 2009 18:00:00 PST http://www.medicalnewstoday.com/articles/170620.php http://www.medicalnewstoday.com/articles/170620.php The American Medical Association's (AMA) House of Delegates adopted a resolution opposing all public and private payer efforts to eliminate physician consultation services. Physicians providing inpatient and outpatient consultation services play a crucial role in diagnosing and caring for patients with complex medical conditions. Medicare / Medicaid / SCHIP Wed, 11 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170506.php http://www.medicalnewstoday.com/articles/170506.php The American Medical Association's (AMA) House of Delegates adopted a resolution calling on the AMA to work with the federal government to enact new federal policies to decrease the public's exposure to endocrine-disrupting chemicals (EDCs). The resolution, introduced by The Endocrine Society, reflects the findings and recommendations of The Endocrine Society's peer-reviewed Scientific Statement ( Endocrinology Tue, 10 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170348.php http://www.medicalnewstoday.com/articles/170348.php Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome. The research team from Cincinnati Children's Hospital Medical Center reports its preclinical laboratory results this week in the early edition of Proceedings of the National Academy of Sciences. Endocrinology Mon, 09 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170265.php http://www.medicalnewstoday.com/articles/170265.php The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone treatment is associated with increased rates of benign breast biopsies, and early and late stages of cancer. Breast Cancer Fri, 06 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170145.php http://www.medicalnewstoday.com/articles/170145.php The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. Thyroid is the official journal of the American Thyroid Association (ATA). The ATA's revised Management Guidelines and accompanying editorials are available free online at Cancer / Oncology Fri, 06 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170052.php http://www.medicalnewstoday.com/articles/170052.php Melatonin, a natural hormone secreted by the own human body, is an excellent sleep regulator expected to replace somniferous, which are much more aggressive, to correct the sleep/wakefulness pace when human biological clock becomes altered. Sleep / Sleep Disorders / Insomnia Fri, 06 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170005.php http://www.medicalnewstoday.com/articles/170005.php Graves' disease is an autoimmune disease in which the patient's own immune system attacks the thyroid gland, causing it to produce too much thyroxine. Thyroxine (T4) is a hormone produced by the thyroid gland that has four iodine molecules attached to its molecular structure. T4, as well as other thyroid hormones help regulate growth and control metabolism in the body. Graves' disease is a form of hyperthyroidism. Endocrinology Thu, 05 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169959.php http://www.medicalnewstoday.com/articles/169959.php The hormones, called androgens, are important in the development of masculine characteristics such as aggression and strength. It is also thought that prenatal androgens affect finger length during development in the womb. High levels of androgens, such as testosterone, increase the length of the fourth finger in comparison to the second finger. Endocrinology Thu, 05 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169964.php http://www.medicalnewstoday.com/articles/169964.php For estrogen replacement to provide stroke protection, it likely must be given soon after levels drop because of menopause or surgical removal of the ovaries, scientists report in the Journal of Neuroscience. Stroke Wed, 04 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169805.php http://www.medicalnewstoday.com/articles/169805.php Researchers from Mount Sinai School of Medicine report that cutting back on the consumption of processed and fried foods, which are high in toxins called Advanced Glycation End products (AGEs), can reduce inflammation and actually help restore the body's natural defenses regardless of age or health status. These benefits are present even without changing caloric or nutrient intake. Biology / Biochemistry Wed, 04 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169806.php http://www.medicalnewstoday.com/articles/169806.php Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). This new information is an important step, say researchers, in understanding the role that hormones play in women's health. Endocrinology Wed, 04 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169808.php http://www.medicalnewstoday.com/articles/169808.php According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), eating a meal quickly, as compared to slowly, curtails the release of hormones in the gut that induce feelings of being full. The decreased release of these hormones, can often lead to overeating. Endocrinology Wed, 04 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/169750.php http://www.medicalnewstoday.com/articles/169750.php Eighteen years ago this month the National Institutes of Health (NIH) announced that it would sponsor a landmark study to examine women and cardiovascular disease. Known as the Women's Health Initiative (WHI), the study enrolled more than 161,000 women. By 2004 however, the government had ended two arms of the study involving estrogen after researchers found it posed a small but detrimental risk for stroke to postmenopausal women taking the hormone. Stroke Wed, 04 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/169743.php http://www.medicalnewstoday.com/articles/169743.php The American Association of Clinical Endocrinologists (AACE) released new medical guidelines for the accurate diagnosis and effective ethical treatment of growth hormone deficiency in affected patients. Growth hormone replacement therapy has proven useful for children and adults with scientifically proven growth hormone deficiency. Endocrinology Wed, 04 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/169745.php http://www.medicalnewstoday.com/articles/169745.php Enobia Pharma announced the initiation of a Phase 2 clinical study of ENB-0040, a bone-targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six-month study will assess the safety, efficacy and pharmacokinetics of ENB-0040 in up to 12 children with HPP. Endocrinology Wed, 04 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/169701.php http://www.medicalnewstoday.com/articles/169701.php Penn Medicine will lead a new national $45 million clinical trial to test whether testosterone therapy can favorably affect certain conditions affecting older men. Low serum testosterone may contribute to a number of problems affecting older men, including decreased ability to walk, loss of muscle mass and strength, decreased vitality, decreased sexual function, impaired cognition, cardiovascular disease and anemia. Men's health